Starling Oncology, Inc.
STLNW- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $163.5K in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding Starling Oncology, Inc. changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Q1 2025 | Change |
|---|---|---|---|
| Holders | 14 | 11 | −3 |
| Shares | 3.58M | 3.52M | −64.0K (−1.8%) |
| Value | $19.0K | $94.9K | +$75.8K (+398.7%) |
New holders (0)
Institutions that held Starling Oncology, Inc. at the end of Q1 2025 but not at the end of Q4 2024.
None.
Sold out (3)
Institutions that held Starling Oncology, Inc. at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Walleye Capital LLC | 53,902 | $280 |
| Citadel Advisors LLC | 12,383 | $87 |
| Bank of America Corp | 200 | $1 |